Order of C-RAD SentinelTM


Press release 2008-07-09

 

Order of C-RAD SentinelTM

 

C-RAD AB with its three fully owned subsidiaries develops new and innovative
solutions for the use in advanced radiation therapy. The company has received
an order from RayClinic, Sweden, of the SentinelTM laser scanner systems. 

 

RayClinic is Sweden's first private cancer clinic focused on advanced
radiotherapy. The treatment techniques are based on world leading well tested
Swedish research developed at the Karolinska Institutet. The clinic specializes
in high quality curative and palliative radiotherapy. RayClinic has ordered two
SentinelTM laser scanner systems from C-RAD Positioning AB. The systems will be
used for positioning of patients prior to treatment where SentinelTM offers
significant improvements in accuracy and efficiency compared to conventional
methods. The order also includes the recently released motion detection
functionality which detects and alerts upon movements of the patient during the
treatment. The patient positioning and motion detection functionalities are
easy to use and well integrated to other systems at the clinic. The SentinelTM
system will also be used in advanced treatments based on respiratory gating. 

Further information about RayClinic: www.rayclinic.com

 

Roger Svensson, CEO, RayClinic AB:

"We are very happy that the close cooperation to develop and evaluate the
Sentinel system worked out so well. The sentinel system will considerably
improve our clinical throughput as well as increase the precision in the
treatment of patients having a critical illness." 

 

 

Erik Hedlund, CEO, C-RAD AB:

"We are pleased with the order of SentinelTM laser scanner systems to RayClinic
AB. These are the first orders to a privately owned radiation therapy clinic.
The systems will be used with full functionality at the clinic and is yet
another confirmation of the Sentinel concept as a valuable tool for increased
accuracy in combination with highly efficient workflow in the critical patient
positioning and motion monitoring procedures within radiotherapy treatments." 

 

 

For further information: 

Erik Hedlund, CEO C-RAD AB, Telefon 018 - 66 69 31, E-post erik.hedlund@c-rad.se

Roger Svensson, CEO RayClinic AB, Telefon 018-410 20 00, E-post
roger.svensson@rayclinic.com 

Attachments

file2.pdf